Agios Pharmaceuticals (AGIO) Ukubelenga kwa Stock
Agios Pharmaceuticals
Ipimo lya nomba $32.60Yasungwa 25 Sep 2026 19:59 UTC
Ukubula -0.82%
Cipimo ca AI : AGIO
AI ileposa chilango ca nshita ya kucila ku bushiku bumo bwa kucita malishiti, ku mpela ya mulungu na ku mpela ya mweshi. Ukukula kulapimwa ukutula ku nshita ya kucila. Aya ni makani ya statistics, te malangililo ya kubika ndalama.
Ipimo mu nshiku 6 ishacita
Premium ilasanga ifyo AI ilatasha ukucita pa 1 day, 1 week na 1 month pa stock iyi na pa stock shonse shimbi.
Fungula Premium🔒 Ukukwata kwa ifipimo
Umulandu wa forecast — bonse ba kale pamo na nshita ya kucila — ni cipande ca Premium.
Fungula PremiumPa Kampani Ici
Agios Pharmaceuticals, Inc. develops therapeutic agents for the treatment of cancer. The company’s drug development efforts focus on glycolysis, fatty acid metabolism, and autophagy. Agios Pharmaceuticals operates in the United States.
